The Biden-Harris administration proposes expanding Medicare and Medicaid coverage for costly anti-obesity medications like Wegovy and Ozempic, sparking debate over drug pricing and accessibility. The move aims to address the high cost of these life-changing medications, currently priced as high as $1,000 per month, while Novo Nordisk, the manufacturer, defends its pricing strategy.
Eli Lilly’s stock price jumped after the Biden administration proposed expanding Medicare and Medicaid coverage for anti-obesity medications, potentially boosting sales of drugs like Mounjaro and Zepbound. The move aims to reduce healthcare costs and combat obesity.
Popular social media platform TikTok is implementing stricter community guidelines to restrict content related to weight loss drugs and anabolic steroids, effective May 17. This move aims to promote self-esteem and prevent negative social comparisons. The prohibition extends to content such as before-and-after photos and the marketing of weight loss products. However, discussions on medically necessary health interventions under professional guidance are still permitted.
